Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A&O Shearman is a premier global law firm formed in May 2024 through the merger of the UK-based Allen & Overy and the US-based Shearman & Sterling. The firm operates as a significant legal advisor to the life sciences, pharmaceutical, and healthcare industries, providing counsel on high-stakes matters including cross-border M&A, intellectual property litigation, and regulatory compliance. With a massive global footprint, the firm supports biotech companies through all stages of growth, from venture financing to large-scale commercialization and patent protection. Their Life Sciences practice group is recognized for handling complex licensing agreements and multi-jurisdictional disputes for global pharma giants. As one of the largest law firms in the world by revenue, A&O Shearman serves as a critical infrastructure partner for the global healthcare innovation ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allen Overy Shearman Sterling.